Jenseits von Mendel

• Literatur

• 1 Beauchamp T, Childress J. Principles of Biomedical Ethics. 5th ed. New York, Oxford: Oxford University Press; 2001
• 2 Meincke U, Kosinski C, Zerres K, Maio G. Psychiatrische und ethischen Aspekte der genetischen Diagnostik am Beispiel von Chorea Huntington. Nervenarzt 2003; 74 (Suppl. 05) 413-419.
• 3 DeGrazia D. The ethical justification for minimal paternalism in the use of the predictive test for Huntington’s disease. J Clin Ethics 1991; 2 (Suppl. 04) 219-28 discussion 228-40.
• 4 Guidelines for the molecular genetics predictive test in Huntington’s disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea. Neurology 1994; 44 (Suppl. 08) 1533-1536.
• 5 Marckmann G. Einführung eines klinischen Ethik-Komitees (KEK). In: Napiwotzky A, Student JC. editors. Was braucht der Mensch am Lebensende? Ethisches Handeln und medizinische Machbarkeit. Stuttgart: Kreuz; 2007: 134-147.
• 6 Rieß O, Schöls L. editors. Neurogenetik. Stuttgart: Kohlhammer; 2002
• 7 Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 2007; 6 (Suppl. 07) 652-662.
• 8 Klein C, Schlossmacher MG. The genetics of Parkinson disease: Implications for neurological care. Nat Clin Pract Neurol 2006; 2 (Suppl. 03) 136-146.
• 9 Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S. et al. Mutations in LRRK2 cause autosomal- dominant parkinsonism with pleomorphic pathology. Neuron 2004; 44 (Suppl. 04) 601-607.
• 10 Hedrich K, Winkler S, Hagenah J, Kabakci K, Kasten M, Schwinger E. et al. Recurrent LRRK2 (Park8) mutations in early-onset Parkinson’s disease. Mov Disord 2006; 21 (Suppl. 09) 1506-1510.
• 11 Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ. et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004; 62 (Suppl. 09) 1619-1622.